SUNNYVALE, Calif., Nov. 7 /PRNewswire-FirstCall/ -- Cepheid (Nasdaq: CPHD)
today announced that its executives will be speaking at the following investor
conferences, and invited investors to participate via webcast.
Credit Suisse Global Health Care Conference, Phoenix, AZ
Friday, November 14, 2008 at 8.00 a.m. Mountain Time
Piper Jaffray Health Care Conference, New York, NY
Tuesday, December 2, 2008 at 2.00 p.m. Eastern Time
Accessing Webcasts
To access the live webcasts for these events, please visit Cepheid's
website at http://www.cepheid.com/investors at least 15 minutes before the
scheduled start time to download any necessary audio or plug-in software. A
replay of the webcast will be available shortly following the presentation and
will remain available for at least 90 days.
About Cepheid
Cepheid (Nasdaq: CPHD), based in Sunnyvale, Calif., is an on-demand
molecular diagnostics company that develops, manufactures, and markets
fully-integrated systems and tests for genetic analysis in the clinical,
industrial and biothreat markets. The Company's systems enable rapid,
sophisticated genetic testing for organisms and genetic-based diseases by
automating otherwise complex manual laboratory procedures. Cepheid's
easy-to-use systems integrate a number of complicated and time-intensive
steps, including sample preparation, DNA amplification and detection, which
enable the analysis of complex biological samples in its proprietary test
cartridges. Through its strong molecular biology capabilities, the Company is
focusing on those applications where rapid molecular testing is particularly
important, such as identifying infectious disease and cancer in the clinical
market; food, agricultural, and environmental testing in the industrial
market; and identifying bio-terrorism agents in the biothreat market.
CONTACTS:
For Media Inquiries: For Investor Inquiries:
Jared Tipton Jacquie Ross
Cepheid Corporate Communications Cepheid Investor Relations
Tel: (408) 400-8377 Tel: (408) 400-8329
jared.tipton@cepheid.com jacquie.ross@cepheid.com
SOURCE Cepheid
